Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Retatrutide is an investigational peptide that acts on three receptors at once GLP-1, GIP, and glucagon
Consistent with in vitro findings, IHC staining of OSCC xenograft tumors showed an increase of p-P38 levels in Semaglutide-treated groups compared to controls, while total P38 expression remained unchanged
Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks
However, it may occur indirectly through mechanisms such as dehydration from gastrointestinal side effects, blood pressure changes, or hypoglycemia, particularly in patients taking insulin or sulfonylureas
Enter your vial size, your BAC water volume, and your target dose
